Should I Buy IMRN? IMRN 2026 Analysis

Should You Buy Immuron Ltd (IMRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.810

1 Day change

3.33%

52 Week Range

2.390

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price is in a clear downtrend (bearish MAs + weakening momentum) with no near-term catalyst support.
Price (0.80) is below the first support (S1 0.83), increasing the odds of further downside toward S2 (0.771) before any sustainable bounce.
With no Intellectia buy signals today and no news/analyst/financial positives to lean on, the risk/reward is unfavorable for an impatient buyer.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend across long-, mid-, and short-term horizons.
Momentum: MACD histogram is negative (-0.00347) and expanding lower, suggesting downside momentum is strengthening.
RSI (6): 22.9 (oversold on a short lookback), which can allow a short-term bounce, but oversold alone is not a reliable buy signal in a downtrend.
Key levels: Pivot 0.926; resistance R1 1.021 / R2 1.08. Support S1 0.83 (broken, since price is 0.80) and S2 0.771 (next downside magnet).

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Potential technical mean-reversion bounce due to short-term oversold RSI (6).
- Pattern-based projection suggests modest positive drift over the next month (+4.29%), though confidence is limited without catalysts.

Neutral/Negative Catalysts

- Strong bearish structure (SMA alignment) and negative, worsening MACD momentum.
- Price trading below S1 support (0.83), raising the probability of a move toward S2 (0.771).
- No news in the past week: lack of event-driven catalysts to reverse sentiment.
- Hedge funds and insiders: neutral, offering no supportive flow signal.
- Broader tape: market was down (S&P 500 -0.48%), which can pressure small caps.

Financial Performance

Financial snapshot unavailable (data error: list index out of range), so no quarter/season growth assessment can be made from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target changes were provided, so there is no observable Wall Street consensus shift to support a buy thesis.
Net take: without positive coverage/trend in targets, there is no external validation catalyst from analysts in the current dataset.

Analyst Rating

Wall Street analysts forecast IMRN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMRN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold